Cargando…
Evaluating interventions to facilitate opioid agonist treatment access among people who inject drugs in Toronto, Ontario during COVID-19 pandemic restrictions
BACKGROUND: In March 2020, following a provincial COVID-19 emergency declaration, modifications to opioid agonist treatment (OAT) were introduced in Ontario, Canada to promote treatment access amid the pandemic and ongoing opioid overdose crisis. Modifications included federal exemptions to facilita...
Autores principales: | Bouck, Zachary, Scheim, Ayden I., Gomes, Tara, Ling, Vicki, Caudarella, Alexander, Werb, Dan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier B.V.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9005368/ https://www.ncbi.nlm.nih.gov/pubmed/35447476 http://dx.doi.org/10.1016/j.drugpo.2022.103680 |
Ejemplares similares
-
The Ontario Integrated Supervised Injection Services Cohort Study of People Who Inject Drugs in Toronto, Canada (OiSIS-Toronto): Cohort Profile
por: Scheim, Ayden I., et al.
Publicado: (2021) -
Disease-related stigma among people who inject drugs in Toronto amidst the COVID-19 pandemic
por: Bowles, Jeanette M., et al.
Publicado: (2023) -
Service utilization patterns and characteristics among clients of integrated supervised consumption sites in Toronto, Canada
por: Nassau, Tanner, et al.
Publicado: (2022) -
Evaluating networked drug checking services in Toronto, Ontario: study protocol and rationale
por: Maghsoudi, N., et al.
Publicado: (2020) -
Trends in Rates of Opioid Agonist Treatment and Opioid-Related Deaths for Youths in Ontario, Canada, 2013-2021
por: Rosic, Tea, et al.
Publicado: (2023)